The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy

Abstract

Participants who meet the Week 16 threshold of ⩾5% weight loss are likely to maintain clinically significant weight loss after 1 year of treatment. Further evaluations are required to evaluate improvements in measures of cardiovascular and metabolic risk.